Preferred Label : Galactosemia III;
Symbol : GALAC3;
CISMeF acronym : GALAC3;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Udp-galactose-4-epimerase deficiency; Galactose epimerase deficiency; Gale deficiency;
Description : Epimerase-deficiency galactosemia was originally described as a benign condition in
which GALE impairment is restricted to circulating red and white blood cells (Gitzelmann,
1972). Fibroblasts, liver, phytohemagglutinin-stimulated leukocyes, and Epstein Barr
virus-transformed lymphoblasts from these patients all demonstrated normal or near-normal
levels of GALE, leading to the designation 'peripheral' (or 'isolated') epimerase
deficiency. A second form of epimerase deficiency became apparent in which a patient,
despite normal;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutations in the UDP-galactose-4-epimerase gene, 'severe' form (GALE, 606953.0008); Caused by mutations in the UDP-galaltose-4-epimerase gene, 'mild' form (GALE, 606953.0001).;
Laboratory abnormalities : Galactosemia; Galactosuria; Aminoaciduria; UDP-galactose-4-epimerase deficiency in all cells ('generalized' or 'severe' form);
Prefixed ID : #230350;
Origin ID : 230350;
UMLS CUI : C0751161;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT